Pharmacogenetics of EGFR in lung cancer: perspectives and clinical applications

Author： Mayo Clara   Bertran-Alamillo Jordi   Molina-Vila Miguel Ángel   Giménez-Capitán Ana   Costa Carlota   Rosell Rafael  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.13, Iss.7, 2012-05, pp. : 789-802

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Clinical Pharmacology of EGFR/Met Inhibitors in Non-Small Cell Lung Cancer

By  

Current Drug Targets, Vol. 15, Iss. 14, 2014-01 ,pp. : 1263-1272

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical applications of pharmacogenetics in psychiatry

By Staddon Susan   Arranz Maria   Mancama Dalu   Mata I.   Kerwin Robert  

Psychopharmacology, Vol. 162, Iss. 1, 2002-06 ,pp. : 18-23

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacogenetics of irinotecan: clinical perspectives on the utility of genotyping

By Innocenti Federico   Ratain Mark J  

Pharmacogenomics, Vol. 7, Iss. 8, 2006-12 ,pp. : 1211-1221

Future Medicine

Access to resources Recommend Favorite

Gefitinib, vinorelbine and EGFR mutations in lung cancer

By  

Inpharma, Vol. 1, Iss. 1590, 2007-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Cyclosporin and Organ Specific Toxicity: Clinical Aspects, Pharmacogenetics and Perspectives

By  

Current Clinical Pharmacology, Vol. 3, Iss. 3, 2008-09 ,pp. : 166-173

Bentham Science Publishers

Access to resources Recommend Favorite